Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Patscheke

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|January 1, 1997
Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasmaK H Reuner, F Litfin, H Patscheke
Thrombosis Research|February 1, 1984
Optical shape change analysis in stirred and unstirred human platelet suspensions. A comparison of aggregometric and stopped-flow turbidimetric measurementsH Patscheke, D Dubler, D Deranleau, et al.
Biochemical Pharmacology|February 1, 1988
Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligandH Zehender, E C Witte, H P Wolff, et al.
Der Nervenarzt|January 19, 2000
[Grand mal series after Ecstasy abuse]M Theune, W Esser, K F Druschky, et al.
Blood|September 1, 1992
Contact-induced neutrophil activation by platelets in human cell suspensions and whole bloodA Ruf, R F Schlenk, A Maras, et al.
British Journal of Haematology|May 12, 1998
Characterization of the thromboxane synthase pathway product 12-oxoheptadeca-5(Z)-8(E)-10(E)-trienoic acid as a thromboxane A2 receptor antagonist with minimal intrinsic activityA Ruf, R Mundkowski, I Siegle, et al.
Biomedica Biochimica Acta|January 1, 1984
Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden deathH Patscheke, K Stegmeier, B Müller-Beckmann, et al.
Clinical Pharmacology and Therapeutics|February 1, 1986
The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177H Patscheke, C Staiger, G Neugebauer, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177C Staiger, H Patscheke, G Neugebauer, et al.
International Journal of Sports Medicine|June 2, 2000
Activation of blood platelets in response to maximal isometric exercise of the dominant armL Röcker, S Günay, H C Gunga, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|January 1, 1997
Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasmaK H Reuner, F Litfin, H Patscheke
Thrombosis Research|February 1, 1984
Optical shape change analysis in stirred and unstirred human platelet suspensions. A comparison of aggregometric and stopped-flow turbidimetric measurementsH Patscheke, D Dubler, D Deranleau, et al.
Biochemical Pharmacology|February 1, 1988
Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligandH Zehender, E C Witte, H P Wolff, et al.
Der Nervenarzt|January 19, 2000
[Grand mal series after Ecstasy abuse]M Theune, W Esser, K F Druschky, et al.
Blood|September 1, 1992
Contact-induced neutrophil activation by platelets in human cell suspensions and whole bloodA Ruf, R F Schlenk, A Maras, et al.
British Journal of Haematology|May 12, 1998
Characterization of the thromboxane synthase pathway product 12-oxoheptadeca-5(Z)-8(E)-10(E)-trienoic acid as a thromboxane A2 receptor antagonist with minimal intrinsic activityA Ruf, R Mundkowski, I Siegle, et al.
Biomedica Biochimica Acta|January 1, 1984
Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden deathH Patscheke, K Stegmeier, B Müller-Beckmann, et al.
Clinical Pharmacology and Therapeutics|February 1, 1986
The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177H Patscheke, C Staiger, G Neugebauer, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177C Staiger, H Patscheke, G Neugebauer, et al.
International Journal of Sports Medicine|June 2, 2000
Activation of blood platelets in response to maximal isometric exercise of the dominant armL Röcker, S Günay, H C Gunga, et al.
Pageof 5